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SINTESIS DAN PENCIRIAN BIOSERAMIK HIDROKSIAPATIT 
BERLIANG MESO 
 
ABSTRAK 
 
Hidroksiapatit (HA) berliang meso dengan saiz liang yang lebih kecil dalam 
julat nano dan taburan saiz liang yang lebih sempit merupakan calon yang lebih 
sesuai untuk memperbaiki profil pelepasan ubat dengan mempamerkan pelepasan 
yang lebih lestari dan seragam. Kajian ini dijalankan untuk menyiasat keupayaan 
pengisian dan pelepasan ubat bagi HA berliang meso, yang disintesis melalui suatu 
mekanisma penghimpunan-diri antara HA dan surfaktan berkation 
desiltrimetilammonium bromida (C10TAB) dengan kaedah pemendakan. Beberapa 
parameter seperti teknik mengawal pH, tempoh penuaan dan nisbah air telah dicuba 
semasa sintesis untuk mengkaji kesan masing-masing terhadap sifat kebolehjerapan 
HA. Pelbagai teknik pencirian termasuk pembelauan sinar-x, penjerapan gas nitrogen 
dan mikroskopi imbasan elektron telah digunakan untuk mengkaji struktur dan ciri-
ciri liang bagi HA berliang meso. Kombinasi parameter yang terdiri daripada nisbah 
air (larutan C10TAB-phosphate dan calcium) 140 : 20 ml dengan pengawalan pH 
berterusan dan tempoh penuaan 24 jam didapati telah memberikan ciri-ciri liang dan 
kebolehjerapan terbaik. HA berfasa tulen dengan kelebaran liang 2 – 6 nm dan luas 
permukaan 73.3 m
2
/g telah berjaya disintesis menggunakan parameter-parameter 
tersebut. Ujian penghantaran ubat in vitro telah dijalankan dengan menggunakan 
ibuprofen sebagai ubat dan HA berliang meso sebagai pengangkut. HA berliang 
meso tersebut telah mempamerkan kapasiti pengisian ubat sebanyak 45.48 mg/g dan 
berupaya  melepaskan ubat secara berterusan selama 52 jam. Selain itu, HA  berliang  
 
meso dalam bentuk granul sfera berdiamater 1 – 25 µm juga telah berjaya disintesis 
melalui teknik sembur-kering. 
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SYNTHESIS AND CHARACTERISATION OF MESOPOROUS 
HYDROXYAPATITE BIOCERAMICS 
 
ABSTRACT 
 
Mesoporous hydroxyapatite (HA) with smaller pore size in the nano range 
and with narrower pore size distribution is a better candidate to provide a more 
favourable drug release profile by exhibiting a more uniform and sustained release. 
This research was conducted to investigate the drug impregnation and release 
capability of mesoporous HA synthesised via a self-assembly mechanism between 
HA and cationic surfactant decyltrimethylammonium bromide (C10TAB) through a 
co-precipitation route. Different parameters such as pH-control technique, ageing 
duration, and water ratio were attempted during the synthesis to investigate their 
respective influence on the sorption properties. Various characterisations techniques 
including x-ray diffraction, nitrogen gas adsorption and scanning electron 
microscopy were carried out to examine the structure and pore characteristics of the 
mesoporous HA. It was found that the combination of parameters which rendered the 
best pore characteristics and sorption properties consisted of water ratio (C10TAB-
phosphate and calcium solution) of 140 : 20 ml with continuous pH-control and 24-
hour ageing. Using these parameters, a phase-pure HA with pore width 2 – 6 nm and 
surface area 73.3 m
2
/g was synthesised. An in vitro drug delivery test was also 
conducted using ibuprofen as a drug and mesoporous HA as a carrier. The 
mesoporous HA showed a drug impregnation capacity of 45.48 mg/g and was able to 
release drug continuously for 52 hours. In addition, mesoporous HA in the form of  
 spherical granules with diameter 1 – 25 µm were also successfully produced through 
 
a spray-drying method. 
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CHAPTER 1 
 
INTRODUCTION 
 
 
The emergence of the term ‘bioceramic’ was brought about by a revolution 
that involved the innovative use of specially designed ceramics for the repair, 
reconstruction, and replacement of diseased or damaged parts of the body (Albee and 
Morrison, 1920; Boutin, 1972; Hulbert et al., 1970 and 1972). Examples of 
bioceramics include ceramic materials such as calcium phosphates (e.g., 
hydroxyapatite, tricalcium phosphate, carbonate apatite, fluoroapatite), silica, 
bioactive glass, zirconia, and alumina. Bioceramics may be bioinert (e.g., alumina 
and zirconia), resorbable (e.g., tricalcium phosphate), bioactive (e.g., hydroxyapatite, 
bioactive glasses, and glass-ceramics), or porous for tissue ingrowth (e.g., 
hydroxyapatite-coated metals) (Hench, 1998). 
 
Hydroxyapatite (HA) is one of the calcium phosphate ceramics which has 
high bioactivity and biocompatibility with human bone tissues as it is part of the 
bone mineral composition (Shackelford, 2005). Due to this, it has been studied 
extensively and used as a bone scaffold and drug delivery system. HA has been used 
widely in the medical field and dentistry. For instances, HA can be used for dental 
implants, periodontal pocket obliteration, alveolar ridge augmentation, maxillofacial 
reconstruction, spinal surgery, and otolaryngological (Hench and Wilson, 1993). In 
addition, HA also can be used for delivering drug in treating osteomyelitis (Itokazu 
et al. 1995 and 1998) and cancer (Uchida et al., 1992). 
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Later, porous bioceramics were found to be a more potential scaffold 
(compared to dense bioceramics) as bone implants. Although the formation of pores 
in bioceramics may adversely affect mechanical properties, the advantages provided 
by the pores are crucial in repairing bone defects. The porosity within certain 
bioceramics can be beneficial to in vivo bone bonding ability due to: (a) larger 
surface area can induce higher bioactivity and results in a higher tendency to 
bioresorb, (b) interconnected pores (if available) can provide a framework for bone 
growth into the matrix of the implant and lead to better fixation with surrounding 
tissues which can increase further bone growth, (c) interconnected porosity functions 
as an organisation of vascular canals for transporting blood and nutrition to the bone 
(Nandi et al., 2009). 
 
 
1.1 Dense Versus Porous Hydroxyapatite 
Both dense and porous HA can be used for biological implants. Both of them 
are used for different purposes and also provide different advantages.  
 
The use of dense HA (DHA) ceramic offers a greater mechanical resistance 
and limited degradation, therefore making it a desirable substitute for hard bone such 
as cortical bone. However, formation of fibrous tissue (instead of vascularised tissue) 
was observed in the bone/implant interface (Zhang and Vecchio, 2006). As for the 
porous HA (PHA), its porosity gives rise to better osteoconductive property which is 
essential for bone tissue growth. Nevertheless, because of their low resistance to 
mechanical stress, PHA ceramics were only indicated for use in non-load-bearing 
area (Andrade et al., 2002).  
3 
 
 
The study of Han et al. (2004) reported that PHA ceramic was only used as 
cancellous bone graft substitute materials in non-load-bearing situations. Although a 
DHA ceramic has more superior mechanical performance than a porous ceramic, its 
applications in load-bearing situations such as artificial joints have been restricted by 
its low toughness and low flexural strength. Furthermore, the bone ingrowth property 
of PHA is much better than that of DHA. Since pore size and porosity can adversely 
affect the mechanical properties of HA, a balance between the needs for 
osteoconductivity and favourable mechanical properties must be maintained. 
 
 
1.2 Mesoporous Hydroxyapatite 
Mesoporous (pore width between 2 and 50 nm) HA has been studied since 
the 21st century because it was believed that its combination of superior pore 
characteristics, high biocompatibility, and high bioactivity would lead to a 
breakthrough when being applied as a drug delivery system (Li et al., 2008; Yao et 
al., 2003). On the other hand, macroporous (pore width > 50 nm) HA was reported to 
exhibit ‘burst’ release profile of drug (Radin et al., 2005), which released 
unnecessarily large amount of drug at the initial stage. This could shorten the drug 
release duration of the HA. Therefore, mesopores, instead of macropores, were 
desired because they can create larger surface area for drug adsorption and provide 
better pore characteristics for better release profile.  
 
Other than that, in comparison to mesoporous silica which exhibited superior 
pore characteristics and has been widely studied for its drug delivery behaviour 
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(Trewyn et al., 2004; Slowing et al., 2008), mesoporous HA might be more suitable 
in treating bone diseases because its higher bioactivity and osteoconductivity would 
help to heal the tissues at the defective part while delivering drug, whereas the 
bioinertness of silica would not allow it to contribute to the recovery of bone tissues. 
In short, mesoporous HA could serve not only as a drug delivery system, but also as 
a scaffold simultaneously. 
 
The methods to synthesise mesoporous HA include soft-templating (Li et al., 
2008; Yao et al., 2003). The soft-templating method proposed by Yao et al. (2003) 
involves the use of surfactant to form micelles template for creating mesopores in the 
HA. Li et al. (2008) showed that higher ageing duration (120 – 160 °C) could create 
smaller pore width (ca. 2 nm) using the proposed procedure. To date, the synthesis of 
mesoporous HA bioceramics with pore characteristics similar to that of mesoporous 
silica is a great challenge. However, such studies are worth attempting to investigate 
the potential of mesoporous HA in various applications. 
 
 
1.3 Problem Statements 
HA could be synthesised by different pH-control techniques i.e., initial 
control (Li et al., 2008; Yao et al., 2003) and continuous control (Li et al., 2009; He 
et al., 2009; Mobasherpour et al., 2007; Pang and Bao, 2003). However, there was no 
study carried out to compare the effect of both techniques on the pore characteristics 
of mesoporous HA. Hence, both techniques were adopted in this study to compare 
their effect. 
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Different ageing durations were reported to create different pore size 
distribution in zirconia, titania, and silica (Suh et al., 2000; Suh and Park, 2002). 
However, the effect of ageing duration on the mesopores of HA has not been 
reported yet. Therefore, the effect of ageing duration on the surface area and pore 
size distribution of mesoporous HA should be investigated to provide a better 
understanding. 
 
Previous studies conducted to synthesise mesoporous HA through co-
precipitation method had used water in the amount of 100 ml to prepare 
decyltrimethylammonium bromide (C10TAB)-phosphate solution and 60 ml to 
prepare calcium solution (Li et al., 2008; Yao et al., 2003). However, no particular 
reason in choosing this ratio was explained. Thus, various water ratios were used 
during synthesis to study their effect on the pore characteristics of HA. 
 
Spherical HA granules were preferred over the one with irregular 
morphology since the latter was reported to cause inflammatory reactions 
(Laquerriere et al., 2003; Paul and Sharma, 1999). However, the synthesis of 
spherical mesoporous HA granules through a spray-drying technique has not been 
attempted before. Thus, such synthesis was carried out to study the characteristics of 
spherical mesoporous HA granules. 
 
 
1.4 Objectives 
1. To synthesise mesoporous HA using soft-templating method and to obtain 
spherical mesoporous HA granules using a spray-drying technique. 
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2. To study the effect of various synthesis parameters (e.g., pH-control 
technique, ageing duration, and water ratio) on the sorption properties of 
mesoporous HA. 
3. To study the in vitro drug (ibuprofen) delivery behaviour of mesoporous HA. 
 
 
1.5 Outline of Study 
This study basically consisted of four main parts. 
I. Synthesis of mesoporous HA with various parameters. 
II. Characterisation of mesoporous HA 
III. In vitro delivery of ibuprofen drug using mesoporous HA  
IV. Synthesis of spherical mesoporous HA granules. 
 
In Part I, the synthesis method was adopted from that of Yao et al. (2003) and 
Li et al. (2008), which involved the self-assembling between HA and cationic 
surfactants. The parameters studied included water ratio, pH-control technique and 
ageing duration. In Part II, the synthesised mesoporous HA was characterised to 
study its phase, sorption properties, surface morphologies, and functional groups. In 
Part III, in vitro ibuprofen drug delivery tests were conducted using synthesised 
mesoporous and synthesised dense HA. The results for both samples were compared 
to study the effect of pores in drug delivery. The reasons to choose ibuprofen drug 
were, firstly, the molecular size of ibuprofen is 1.0 x 0.6 nm (Vallet-Regi et al., 
2001), which could be fit into mesopores. Secondly, ibuprofen is a common and 
highly available pharmaceutical drug which is being used as an analgesic and also as 
an anti-inflammatory drug (e.g., for medical treatment of rheumatoid arthritis) 
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(Manzano et al., 2008). Lastly, the high availability of studies on ibuprofen delivery 
by carriers based on mesoporous silica (Du and He, 2010; Jin and Liang, 2010; 
Izquierdo-Barba et al., 2009; Manzano et al., 2008; Qu et al., 2006; Vallet-Regi et al., 
2001) could give a broader view to provide better understanding in this field. As for 
Part IV, a spray-drying method was adopted to produce spherical mesoporous HA 
granules and their characteristics were compared with those of non-spray-dry. 
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CHAPTER 2 
 
LITERATURE REVIEW 
 
  
2.1 Biomaterials 
A biomaterial is defined as any material used to make devices to replace a 
part or a function of the body in a safe, reliable, economic, and physiologically 
acceptable manner (Park and Lakes, 2007). A biomaterial is a synthetic material used 
to function in intimate contact with living tissue or to replace part of a living system. 
A biomaterial is different from a biological material, such as bone, that is produced 
by a biological system (Shi and Jiang, 2006). Biomaterials is an interdisciplinary 
research topic which involves the knowledge of three different fields: (1) materials 
science and engineering processing-structure-property interrelationship of synthetic 
and biological materials including metals, ceramics, polymers, composites, tissues; 
(2) biology and physiology cell and molecular biology, anatomy, animal and human 
physiology, and (3) clinical sciences dentistry, ophthalmology, orthopaedics, plastic 
and reconstructive surgery, cardiovascular surgery, neurosurgery, immunology, 
histopathology, experimental surgery, veterinary medicine and surgery (Shi, 2006). 
Since the goal of using biomaterials is to improve human health by restoring the 
function of natural living tissues and organs in the body, the knowledge on the 
relationships between the properties, functions, and structures of biomaterials must 
be mastered. Therefore, the subject of biomaterials basically includes three aspects of 
study i.e., biological materials, implant materials, and interaction between the two in 
the body (Park and Lakes, 2007).  
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2.1.1 Requirements for Biomaterials 
In order to use a biomaterial effectively and successfully, attentions have to 
be given to the appropriate material selection, engineering design and manufacturing 
process. It is extremely important to select the suitable material to provide the 
appropriate properties as well as being biocompatible, even though proper design and 
manufacture are also essential. Both the influence of mechanical and chemical 
factors can also be critical, e.g., causing fatigue, corrosion fatigue, stress corrosion, 
wear, and fracture (William, 1991). 
  
Aside from the requirements mentioned above, other factors that must be 
considered are: the health condition of the recipient, and the competency of the 
surgeon who implants and monitors its progress. Several criteria for choosing an 
implant include: 
1. Acceptance of the implant to the tissue surface, i.e., biocompatibility 
2. Pharmacological acceptability (non-toxic, non-allergenic, non-immunogenic,  
     non-carcinogenic) 
3. Chemically inert and stable (no time-dependent degradation) 
4. Adequate mechanical strength 
5. Adequate fatigue life 
6. Sound engineering design 
7. Proper weight and density 
8. Relatively inexpensive, reproducible, and easy to fabricate and process for large- 
     scale production (Park and Lakes, 2007) 
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2.1.2 Examples of Biomaterials 
Biomaterials are divided into several categories based on their structural, 
chemical, and biological characteristics, for example, as in ceramics, glasses, and 
polymers with a varied degree of bioactivity (Shi, 2006). While biomaterial 
applications involve metals, ceramics, polymers and composites, they are divided 
basically into three types. These are 
(i)  inert or relatively inert with minimal host response 
(ii) bioactive which actually stimulates bonding to the surrounding tissue and  
(iii) biodegradable which resorb in the body over a period of time (William, 1991). 
  
Table 2.1 listed some of the advantages, disadvantages, and applications of 
four groups of synthetic (manmade) materials used for implantation (Park and Lakes, 
2007).  
 
 
2.2 Bioceramics 
“Ceramic” is a term translated from the Greek keramos, which means pottery 
or burned stuff. Ceramics are composed of inorganic and non-metallic materials and 
include pottery, porcelain, refractory materials, clay products, abrasives, porcelain 
enamels, cements, glasses, non-metallic magnetic materials, ferroelectrics, and 
manufactured single crystals (Kingery et al., 1976). 
 
About six decades ago, a revolution occurred in the use of ceramics to 
improve the quality of life (Hench, 1998). The revolution involved the innovative use 
of   specially  designed  ceramics  for  the  repair, reconstruction, and replacement of 
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Table 2.1 Class of materials used in human body (Park and Lakes, 2007) 
 
Materials Advantages Disadvantages Example 
applications 
Polymers  
(nylon, silicone, rubber, 
polyester, 
polytetrafluoroethylene) 
Resilient 
Easy to fabricate 
Not strong 
Deforms with 
time 
May degrade 
Sutures, blood 
vessels, soft 
tissues, hip 
socket, ear, nose 
Metals  
(Ti and its alloys, Co-
Cr alloys, Au, Ag 
stainless steels) 
Strong, tough, 
ductile 
May corrode 
Dense 
Difficult to 
fabricate 
Joint 
replacements, 
dental root 
implants, pacer 
and suture wires, 
bone plates and 
screws 
Ceramics 
(Alumina, zirconia, 
calcium phosphates 
including HA) 
Very 
biocompatible 
Brittle 
Not resilient 
Weak in tension 
Dental and 
orthopaedic 
implants 
Composites  
(carbon-carbon, wire- 
or fibre-reinforced bone 
cement)  
Strong, tailor-
made 
Difficult to make 
Bone cement, 
dental resin 
 
 
diseased or damaged parts of the body (Albee and Morrison, 1920; Boutin, 1972; 
Hulbert et al., 1970, 1972). Hence, the term ‘bioceramics’ emerged. ‘Bioceramics’ are 
defined as any ceramic, glass or glass-ceramics used as a biomaterial, which is a 
material intended to interface with biological systems to evaluate, treat, augment, or 
replace any tissue, organ, or function of the body (Williams, 1999). Similarly, the 
term ‘bioceramics’ also refers to biocompatible ceramic materials that are applicable 
for biomedical or clinical uses (Tanaka and Yamashita, 2008). Bioceramics can be 
polycrystalline (alumina or hydroxyapatite), bioactive glass, bioactive glass-ceramic, 
or bioactive composite (polyethylene–hydroxyapatite) (Hench, 1998). 
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2.3 Types of Bioceramics 
There have been a number of bioceramics which are well-known for their 
potential in biomedical applications. Among them are silica, alumina, zirconia, glass-
ceramics, and calcium phosphates. 
 
 
2.3.1 Silica 
Silica is a bioceramic which plays important roles in bioactive glass 
fabrication (Jones, 2008), allowing apatite nucleation (Cho et al., 1996), coating on 
titanium and hydroxyapatite (Borum and Wilson, 2003; Yoshida et al., 1999), and 
drug delivery (Kortesuo et al., 2000). However, there was no report on the formation 
of bond between pure silica and surrounding tissues so far. Thus, pure silica is 
categorised as a bioinert material which does not play any major role in the repair of 
bone defect. This is supported by the finding of Klein et al. (1995) which confirmed 
that silica content exceeding 60 mol% will give rise to bioinert property. 
Nevertheless, silica is bioresorbable (Ahola et al., 2001) and mesoporous silica 
nanoparticles exhibit a high biocompatibility at concentrations adequate for potential 
pharmacological applications, unlike amorphous silica which showed cytotoxicity 
towards mammalian red blood cells (Slowing et al., 2009). 
 
 
2.3.2 Alumina 
Alumina is widely used for biomedical applications due to its good 
mechanical properties from excellent strength, promising fracture toughness, high 
wear resistance, good biocompatibility, to excellent corrosion resistance (De Aza et 
13 
 
al., 2002). High-density and high-purity (>99.5%) alumina (Al2O3) was the first 
bioceramic widely used in the medical field (Hench, 1998). However, it has a much 
lower tensile strength (259 MPa) than compressive strength (2965 MPa) due to its 
brittleness (i.e., it cannot undergo plastic deformation like metals and plastics) (Park, 
2008), which was a disadvantage for orthopaedic load-bearing applications. Boutin 
(1972) was the first to use alumina ceramic materials as bearing surfaces in artificial 
hips in the early 1970s. Most of the alumina used for implant applications was either 
a polycrystalline solid of high density and purity or an artificially grown colourless 
single crystal similar to sapphire or ruby (Park, 2008). 
 
 
2.3.3 Zirconia 
Phase-stabilised zirconia has become a popular alternative to alumina as a 
structural ceramic (Walpole et al., 2009), especially in total hip replacement (THR) 
applications, because of its substantially higher fracture toughness (10.5 MPa.m
1/2
) 
(Park, 2008). The fracture strength of zirconia ceramic heads was approximately 
double that of alumina heads (5.4 MPa.m
1/2
) (Drouin et al., 1997). In order to achieve 
better mechanical properties, yttrium is added into the crystal structure of zirconia in 
the form of yttrium (III) oxide to form yttria-stabilised zirconia (YSZ). In 
orthopaedic implants, YSZ is commonly used due to its combination of outstanding 
mechanical properties, biocompatibility, and wear behaviour against polyethylene. 
Zirconia has been receiving attention due to its high tensile strength and fracture 
toughness. The superior properties of zirconia allowed it to manufacture femoral 
heads for total hip prostheses that were smaller than the present generation of 
alumina heads (Hench, 1998). The use of zirconia (ZrO2) for biomedical applications 
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was first reported by Helmer and Driskell (Helmer and Driskell, 1969) in 1969. The 
first paper reporting the use of zirconia to manufacture ball heads for THR, which is 
the current main application of this bioceramic, was published by Christel et al. 
(1988) in 1988. Overall, by 2006, more than 600,000 zirconia femoral heads had 
been used as an implant worldwide, mainly in the US and in Europe (Chevalier, 
2006). 
 
 
2.3.4 Glass-ceramics 
Glass-ceramics were developed by Stookey in the early 1960s. Glass-
ceramics are actually polycrystalline ceramics made by controlled crystallisation of 
glasses. Initially, they were applied in photosensitive glasses in which copper, silver 
and gold were precipitated by ultraviolet light irradiation. Such precipitation 
facilitated the nucleation and crystallisation of the glass into a fine grained ceramic 
which possess superior mechanical and thermal properties (Park and Lakes, 2007). 
Two types glass-ceramic have been developed as bioceramics i.e., Bioglass® and 
Ceravital® (Blencke et al., 1978; Hench and Pachall, 1973; Ogino et al., 1980; 
Piotrowski et al., 1975). The compositions of the two glass-ceramics are rather 
similar in terms of SiO2 content (Table 2.2) but Ceravital® is composed of Al2O3, 
TiO2, and Ta2O5 which are important to control the dissolution rate (Park and Lakes, 
2007).  
 
Compared to hydroxyapatite and tricalcium phosphate, bioactive glasses have 
an advantage of being able to be used as a substrate stronger than cortical bone and 
they also possess the ability to form strong chemical bonds with bone. For instance, a 
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Table 2.2          Compositions of Bioglass® and Ceravital® Glass-Ceramics (Park  
                         and Lakes, 2007) 
 
Type Code SiO2 CaO Na2O P2O5 MgO K2O 
Bioglass        
 42S5.6 42.1 29.0 26.3 2.6 - - 
 (45S5)46S5.2 46.1 26.9 24.4 2.6 - - 
 49S4.9 49.1 25.3 23.0 2.6 - - 
 52S4.6 52.1 23.8 21.5 2.6 - - 
 55S4.3 55.1 22.2 20.1 2.6 - - 
 60S3.8 60.1 19.6 17.7 2.6 - - 
        
Cervital*        
 
Bioactive 40-50 30-35 5-10 10-15 2.5-5.0 
0.5-
3.0 
 **Non-
bioactive 
30-35 25-30 3.5-7.5 
7.5-
12.0 
1.0-2.5 
0.5-
2.0 
*The Ceravital composition in weight % while the Bioglass compositions are in 
mol %. 
**In addition Al2O3 (5.0-15.0), TiO2 (1.0-5.0) and Ta2O5 (5.0-15.0) are added. 
 
 
 
glass-ceramic containing apatite and wollastonite exhibited better mechanical 
properties than bone tissue and was able to bond chemically with living bone tissue 
(Ono et al., 1990; Sautier et al., 1994). Similar to other glasses and ceramics, the 
major disadvantage of the glass-ceramic is its brittleness. Besides that, the 
mechanical strength of glass-ceramics cannot be substantially improved because 
varying its composition might compromise its biocompatibility. Thus, they are not 
suitable to be used as load-bearing implants such as joint implants. However, they 
can be used as dental restorative composites, coating material, and fillers for bone 
cement (Park and Lakes, 2007). 
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2.3.5 Calcium phosphates 
Calcium phosphate (CaP) can be crystallised into mono-, di-, tri-, and tetra-
calcium phosphate, hydroxyapatite (HA), carbonate apatite, fluorapatite, α-tricalcium 
phosphate (α-TCP), and β-tricalcium phosphate (β-TCP). Such crystallisation 
depends on the Ca/P ratio, the presence of water and impurities, and the synthesis 
temperature. 
 
HA is an important biomaterial (with a Ca/P ratio of 1.67) present in bones 
and teeth. In fact, it comprises the primary mineral content of bone (43 wt%) 
(Shackelford, 2005), which implies that HA is highly biocompatible in nature. Dense 
HA has been used in orthopaedics or for bone substitutes (Asazuma et al., 2005; 
Mangano et al., 2008; Park, 2008) and dental implants (Layman and Ardoin, 1998). 
Although HA is not osteoinductive, it possesses good osteoconductive properties as 
well as a remarkable ability to bind directly to bone (Chen et al., 2008). Among the 
calcium phosphate bioceramics, stoichiometric HA dissolves and precipitates at the 
lowest rate (Shi and Wen, 2006). Macroporous HA has been studied intensively 
since the 1980s. However, the study of mesoporous (pore width between 2 and 5 nm) 
and microporous (pore width below 2 nm) HA for in vitro or in vivo testing is rather 
new, although they have a great potential to serve as drug delivery systems. There 
are also some other types of apatite ceramics, such as carbonate apatite (CHA) and 
fluoroapatite (FA). However, among the three porous apatites, interest is mainly 
focused on porous HA at present. 
 
Tricalcium phosphate (TCP) has a Ca/P ratio of 1.50, which is similar to that 
of amorphous biological precursors to bone (Bodde et al., 2007). Despite their 
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similarity in composition, TCP and apatites are different, as the former is not found 
in natural bone. TCP has been developed as a bioactive and bioresorbable bone 
substitute due to its higher solubility compared to HA (Shi and Wen, 2006). In 
general, TCP is classified into α-tricalcium phosphate (α-TCP) and β-tricalcium 
phosphate (β-TCP). β-TCP can be converted to α-TCP when it is heated to 1125 °C 
(Rey et al., 2008). More attention has been focussed on β-TCP than on α-TCP for 
biomedical applications due to the instability (Rey et al., 2008) and cytotoxicity (Dos 
Santos et al., 2002) of α-TCP. However, α-TCP can be converted into apatite 
through a hydrothermal treatment (Wakae et al., 2008). Macroporous β-TCP has 
been studied intensively as a scaffold for bone growth and as a matrix for various 
proteins and growth factors. Nevertheless, application of pure β-TCP to bone defect 
repair are limited due to the inferior mechanical properties (compressive strength, 
bending strength, Young’s modulus) of β-TCP when compared to HA (Hench, 1998). 
 
HA, CHA, and FA are different due to the presence of different anion, i.e., 
hydroxyl (OH
-
), carbonate (CO3
2-
), and fluoride (F
-
), respectively. There are 
basically two types of CHA i.e., type A and type B, depending on the position of the 
carbonate
 
in the apatite lattice. For type A, the carbonate ions occupy the hydroxyl 
site. For type B, the ions occupy the phosphate (PO4
3-
) site. In comparison to HA, 
CHA has a composition closer to that of bone mineral (LeGeros, 1981) and has 
higher resorbability (LeGeros and Tung, 1983). This implies that CHA can serve as a 
more favourable bone scaffold which can be replaced completely by new bone. On 
the other hand, FA is formed when the F
-
 occupy the hydroxyl site of apatite. FA has 
higher thermal and chemical stability, and lower resorbability compared to HA (Kim 
et al., 2004A; Krajewski et al., 1990). Besides that, FA also exhibits caries-inhibiting 
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property which does not affect its biocompatibility (LeGeros et al., 1983). However, 
FA is too stable and lacks biological properties and, therefore, might not be a good 
biomaterial when used alone (Downes et al., 1995). Despite that, FA can be used as 
an intermediate layer inserted between HA and zirconia. This will be able to prevent 
any direct contact between both of them which will lead to the decomposition of HA 
to TCP (Kim et al., 2003).  
 
 
2.3.6 Hydroxyapatite 
Hydroxyapatite (HA) is a member of the apatite family. The term “apatite” 
originated from the Greek apatê, which means deceit or deception. It bears such a 
meaning due to its diversity of form and colour (McConell, 1973).  HA has a specific 
crystallographic structure: hexagonal P63/m space group (Albee and Morrison, 1920; 
Andrew et al., 1962; Aoki et al., 1972). However, pure HA is different from 
biological apatites whereby biological apatites contain important minor substituents 
(e.g., CO3
2−
, Na
+
, Mg
2+
) and are more accurately described as carbonate apatite 
(CHA), approximated by the formula (Ca,Mg,Na)10(PO4,HPO4,CO3)(OH)2 
(Ducheyne et al., 1980; Holmes, 1979). Besides constituting the inorganic or mineral 
phases of normal calcified tissue (teeth and bones), biological apatites are also found 
in some pathologic calcifications (dental calculus, heart calcifications, urinary stones, 
soft-tissue calcifications) (Ducheyne et al., 1980; Evans, 1973; Holmes, 1979). 
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2.3.6.1  Chemical Properties of HA 
The rate of HA dissolution in vivo depends on factors including degree of 
crystallinity, crystallite size, processing conditions (temperature, pressure, and partial 
water pressure), and porosity (LeGeros, 1993; LeGeros and Tung, 1983; Moreno et 
al., 1997). The solubility of sintered HA is lower than the unsintered one. HA is 
insoluble in an alkaline solution while soluble in an acidic one and slightly soluble in 
distilled water. These solubility properties are closely related to the biocompatibility 
of HA with tissues and its chemical reactions with other compounds. HA reacts 
actively with proteins, lipids, as well as other inorganic and organic species (Park, 
2008). The rate of solubility is 0.1 mg/year in subcutaneous tissue (Katz and Harper, 
1986).  
 
The solubility of apatite is also affected by substitutions in the apatite 
structure. For example, compared with unsubstituted apatites prepared by 
precipitation or hydrolysis method, strontium, magnesium or carbonate substitution 
causes an increase in solubility (LeGeros, 1981; LeGeros and Tung, 1983) while 
fluoride substitution causes a decrease in solubility (LeGeros, 1981; Moreno et al., 
1997).  
 
 
2.3.6.2  Mechanical Properties of HA 
The mechanical properties of a dense HA are influenced by the properties of 
the apatite powder, the compression and sintering conditions, and porosity. Several 
mechanical properties (e.g., compressive strength) degrade with increasing amount 
of porosity (Denissen et al., 1985). The mechanical properties are highly dependent 
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on the preparation of the apatite powder (Li et al., 2002). The difference in 
preparation methods causes difference in composition and in grain size (small grain 
size tends to give greater fracture toughness). Flexural strength and fracture 
toughness of dense HA was higher in wet than in dry conditions (Denissen et al., 
1985). Meanwhile, higher sintering temperature will increase the density, grain size, 
compressive, flexural, torsional strength and moduli of elasticity in compression 
(Aoki, 1994; De Groot, 1983; Jarcho, 1981). The fracture toughness of HA ceramic 
increased for HA sintered from 1100 to 1150 °C, but made no significant difference 
from 1150 to 1250 °C, and decreased at sintering temperature above 1250 °C (Aoki, 
1994). The modulus of elasticity of HA is 40 – 117 GPa compared with that of 
cortical bone of 12 – 18 GPa (Aoki, 1994). 
 
 
2.3.6.3  Biological Properties of HA 
The biological properties will be discussed based on several aspects. They 
include in vitro cell response and in vivo tissue response (bioactivity, 
osteoconductivity, and osteoinductivity).  
 
The cell response (proliferation, differentiation, phenotypic expression of 
bone markers) to various materials can be demonstrated by in vitro cell culture 
studies. Responses of osteoblast (bone-forming), osteoclast (bone-resorbing), 
odontoblast (dentin-forming) and periodontal (associated periodontal ligament 
attachment) cells to HA have been reported (Craig and LeGeros, 1999; Frondoza, 
1998; Fujimori et al., 1998; Inoue et al., 2004).  
 
21 
 
In vivo tissue response to biomaterials depends mainly on: bioactivity, 
osteoconductivity and osteoinductivity (LeGeros, 2002). Tissue response in terms of 
bone ingrowth also depends on the porosity (pore size, pore structure, degree of pore 
interconnectivity, pore volume). Bioactivity is the ability of the material to directly 
‘bond’ to bone through chemical interaction and not physical or mechanical 
attachment (Hench, 1994; Osborn and Newesely, 1980). In vitro and in vivo 
bioactivity have been investigated by studying the ability of the material to form 
CHA (similar to bone apatite) on its surface (Boyde et al., 1999; Heughebaert et al., 
1988; Kokubo, 1996; LeGeros and Daculsi, 1990; LeGeros et al., 1991A). Apatite 
nano-crystals similar to bone apatite were formed on the surfaces of coralline HA 
crystals and this was associated with ceramic HA for the same amount of time of 
suspension in bovine serum (LeGeros et al., 1991B).  
 
Meanwhile, osteoconductive property was exhibited by HA whereby HA was 
able to serve as a scaffold or template for the formation of new bone tissues along its 
surfaces. Osteoconductive materials allow bone cell attachment, proliferation, 
migration, and phenotypic expression, which bring about formation of new bone on 
the biomaterial and result in a strong interface (LeGeros and LeGeros, 2008). 
Although CaP materials are bioactive and osteoconductive, they are usually not 
osteoinductive (LeGeros, 2002). Despite that, some porous HA exhibited 
osteoinductive property (Kuboki et al., 1998; Ripamonti et al., 1992) and it was 
believed to be influenced by its specific geometry and optimal pore size. 
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2.4 Applications of Bioceramics 
Bioceramics have been widely used in medical applications. Shackelford 
categorised the applications into three main fields, i.e., orthopaedics, dentistry, and 
cancer treatment (Shackelford, 2005). In orthopaedics, bioceramics were used for 
joint replacement (especially total hip replacement) as well as defect and fracture 
repair. The common bioceramics involved were alumina (Al2O3), partially stabilised 
zirconia (ZrO2), and calcium phosphate (e.g., HA, TCP). The potential of 
macroporous HA in repairing bone defects was reviewed by Lew et al. (2011). In 
dentistry, traditional dental porcelains composed of mainly leucite and 
aluminosilicate have been used to repair diseased and decayed teeth. Aside from 
traditional porcelains, alumina ceramics, and glass-ceramic prosthetics, Bioglass
®
 
(Hench, 1998) implants also played important roles in this application. In cancer 
treatment, glass beads and ferromagnetic glass-ceramics have been used for internal 
delivery of therapeutic radiation and local thermal treatment of bone tumours, 
respectively. A typical example of a material used in glass beads was yttria 
(yttrium(III) oxide) aluminosilicate (YAS) glass. Upon neutron bombardment, 
yttrium formed a radioactive isotope (Y-90). Such incorporation of radioactive 
isotope of yttrium during glass melting caused the glass to be highly radioactive with 
the formation of yttria in the glass composition, which was crucial for cancer 
radiotherapy. Ferromagnetic glass-ceramics could be obtained by incorporating 
magnetite in a CaO·SiO2-based matrix. After implantation of the glass-ceramic, an 
alternating magnetic field was applied to create a heating effect that was able to kill 
cancer cells (Shackelford, 2005). 
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2.4.1 Macroporous Hydroxyapatite as Drug Delivery Systems 
Macroporous HA was suitable to be used as an implantable drug delivery 
system because of its high biocompatibility, simplicity and reproducibility. Another 
advantage of HA drug delivery system was the possibility of creating various 
controlled pore sizes to control the release rate of drugs (Uchida et al., 1992). In 
addition, any antibiotics can be placed in the macroporous HA because there was no 
thermal damage to the drug (Shinto et al., 1992). Ma et al. (2008) confirmed that the 
property of ibuprofen was not changed in the loading and releasing processes from 
macroporous HA. Macroporous HA was also favoured for its sustained drug release 
and this was safer compared to a single administration of high concentration of drug 
because chances for the latter to reach the toxic level and cause side effects were 
high (Uchida et al., 1992). Macroporous HA was able to treat diseases like cancer 
(Uchida et al., 1992) and osteomyelitis (Itokazu et al., 1995 and 1998) without any 
complication or inhibition to tissues activities other than the tumours. 
 
However, HA (and other calcium phosphates) exhibited ‘burst’ release profile, 
which was a disadvantage for controlled-release applications (Radin et al., 2005). 
Despite that, one of the effects of porosity on drug release has been confirmed in the 
study of Palazzo et al. (Palazzo et al., 2005) whereby lower porosity of HA showed 
more evident initial burst release. This behaviour was due to the tendency of the drug 
molecules to concentrate themselves on the external macropore walls rather than 
internal pores. The tendency will become higher with the decreasing of the ceramic 
porosity and surface area, because of the difficulty for the drug to reach the internal 
pores during the drug introduction to the carrier. Similar explanation was given by 
Kim et al. (2004B) whereby the initial burst effect was due to the abrupt release of 
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drugs insufficiently entrapped or loosely bound to the surface. In other words, HA 
with higher porosity and smaller pore size would increase the surface area and allow 
larger amount of drug to enter the pores. This was where the idea of using 
mesoporous HA started. 
 
Although the pore characteristics of mesoporous HA were not as good as 
those of mesoporous silica, mesoporous HA may be a more suitable candidate in 
delivering drug to treat bone defects because its high bioactivity and good 
osteoconductivity were beneficial for the growth of bone tissues in defective part. In 
other words, mesoporous HA could serve two purposes at the same time i.e., to 
deliver drug and to be a scaffold. On the other hand, the bioinertness of mesoporous 
silica prohibited it from being a scaffold in treating defective bones. However, up-to-
date, there is no reported study on the performance of mesoporous HA in drug 
delivery yet. 
 
 
2.5 Mesoporous Bioceramics 
After the initial study on macroporous (pore width >50 nm) bioceramics, 
interest was aroused gradually in mesoporous (pore width 2 – 50 nm) bioceramics to 
improve pore characteristics as a result from the discovery of Mobil Composition of 
Matter No. 41 (MCM-41) (Kresge et al., 1992). Ever since MCM-41 was discovered 
and had been a great success, nanoporous (pore width <100 nm) materials have 
received great attention as the presence of nanopores were believed to be capable of 
improving certain properties (e.g., drug release profile) or even rendering new 
properties (e.g., as a catalyst) to a material. However, it is not a simple task to create 
